The Nufarm Limited (ASX: NUF) share price was out of form last month.
The agricultural chemicals company’s shares fell a disappointing 20.2% during November.
This made Nufarm the third-worst performer on the ASX 200 index last month behind only G8 Education Ltd (ASX: GEM) and Smartgroup Corporation Ltd (ASX: SIQ).
Why did the Nufarm share price sink lower in November?
Investors were selling the company’s shares in November after it provided the market with an update on its first half results.
According to the release, during the course of reconciling accounts with German customers, Nufarm identified additional sales rebate claims from customers relating to its 2019 financial year.
Instead of restating its FY 2019 financial statements, management expects to make an adjustment in its first half FY 2020 earnings. While its investigation is ongoing, at this stage it is expecting a negative impact of A$9 million to its first half EBITDA.
Trading conditions remain tough.
Also sending investors to the exits was its update on trading conditions.
The release explained that trading conditions have continued to be difficult so far in FY 2020. This has resulted in lower earnings in all regions for the first quarter compared to the prior year.
One area performing particularly poorly was North America. Management advised that high channel inventories and substantially lower demand in the region has resulted in first quarter EBITDA of approximately A$20 million below the corresponding period. Unfortunately, this is unlikely to be mitigated in the second quarter.
As a result of its poor start to the half, management expects first half EBITDA to be “significantly lower than the prior year.”
Should you buy the dip?
Analysts at Morgan Stanley appear to believe that this share price weakness is a buying opportunity.
According to the note, it has retained its overweight rating and $7.20 price target on the company’s shares.
The broker remains positive on Nufarm despite its disappointing update. It believes its issues are temporary and investors should take advantage of the share price pullback. Especially given its massive Omega-3 opportunity.
The post The Nufarm share price crashed 20% lower in November appeared first on Motley Fool Australia.
Not sure about Nufarm just yet? Then check out these highly rated shares that have been given buy ratings.
Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.
One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…
Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield...
Plus 3 more cheap bets that could position you to profit over the next 12 months!
See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.
- Man bets $221,666 on one ASX stock
- Top analysts name their top 3 ASX blue chip shares for 2019
- 3 quality dividend shares to boost your income
- NEW: Free report names top 3 ASX dividend shares to buy for 2019
- 5 Stocks for Potentially Building Wealth After 50
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019